Health Care Technology Institute
This article was originally published in The Gray Sheet
Executive Director Candace Littell is leaving the privately funded research organization at the end of the year to start a consulting firm that will focus on health policy and payment issues that affect medical technology companies. Littell has been executive director of HCTI since it was founded in 1992 by the Health Industry Manufacturers Association to study the impact of medical technology on health care costs and productivity
You may also be interested in...
FDA's Emergency Use Authorization for Malaria Drugs Could Hinder Trials of Other COVID-19 Treatments
Questions linger about the role the White House played in pushing the EUA, which comes with large product donations from Bayer and Sandoz that are expected to alleviate supply chain pressures for the drugs.
FDA Commissioner Stephen Hahn was added to the White House's pandemic task force as the outbreak grew, but he remained in a background role. That all changed the morning of 18 March, when President Trump tweeted: “I will be having a news conference today to discuss very important news from the FDA concerning the Chinese Virus!” A day later, Hahn was standing with Trump at the podium for the now-daily press briefings on Covid-19.
Approved in February as an on-demand remedy, Nurtec will be filed for migraine prevention after success in Phase III. It could be the first oral preventive therapy and first dual purpose migraine drug.